AbbVie Options Market Prices in 4.2% Swing for July 31 Earnings

AbbVie Inc. (NYSE: ABBV) shares could experience a significant price swing following the company's upcoming earnings release, with the options market pricing in a potential move of 4.2% in either direction. The pharmaceutical giant is scheduled to report its financial results before the market opens on July 31, according to options data compiled by Bloomberg.

Implied Volatility vs. Actual Moves

The implied move derived from options pricing serves as a market-based forecast for post-earnings volatility. A review of AbbVie's last eight quarterly reports reveals that the stock's actual price change has exceeded the implied move in five of those instances, suggesting a tendency for the company's results to surprise investors.

While the stock's reaction has varied, several past reports triggered substantial moves that outpaced expectations:

• January 31, 2025: Shares rose 7.8% versus a 3.8% expected move.
• April 25, 2025: The stock gained 7.6%, exceeding the 5.5% implied move.
• October 30, 2024: AbbVie climbed 6.7%, well above the 3.7% implied move.

Ad

Conversely, the most recent report on April 29, 2026, saw the stock decline just 0.6%, significantly underperforming an implied move of 4.8%. On October 31, 2025, shares fell 4.5%, which was larger than the 3.7% move priced in by the options market.

Context for Investors

The 4.2% implied volatility figure is not a prediction of the stock's direction but rather a measure of the magnitude of the price change anticipated by traders. It reflects the price of options contracts that expire shortly after the earnings announcement and provides a benchmark for gauging the market's reaction.

A stock move greater than the implied 4.2% would suggest the earnings report contained a significant surprise, whether positive or negative. A smaller move would indicate the results and forward guidance were broadly in line with investor and analyst consensus.